Evidence map›Paper›PMID 31798466›Full record

ArticleFrontiers in physiology2019

Proteomic Markers of Non-functional Overreaching During the Race Across America (RAAM): A Case Study.

Edward K Merritt, David C Nieman, Brian R Toone, Arnoud Groen, Artyom Pugachev

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. SAA4: An Underdog Within the Serum Amyloid a Superfamily?International journal of molecular sciences · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Exercise immunology: Future directions.Journal of sport and health science · 2020
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Edward K MerrittDepartment of Kinesiology, Southwestern University, Georgetown, TX, United States.
David C NiemanNorth Carolina Research Campus, Appalachian State University, Kannapolis, NC, United States.
Brian R TooneDepartment of Mathematics and Computer Science, Samford University, Homewood, AL, United States.
Arnoud GroenProteiQ Biosciences GmbH, Berlin, Germany.
Artyom PugachevProteiQ Biosciences GmbH, Berlin, Germany.
Appalachian State University · USSamford University · USSouthwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a previous study, proteomics procedures identified blood proteins as potential overreaching and overtraining biomarkers, and a targeted proteomics panel of 21 proteins was developed. PURPOSE: To measure targeted blood protein changes in an ultraendurance cyclist competing in RAAM.

methodsThe athlete underwent testing 4-week pre-RAAM and 4-day post-RAAM to determine body composition and aerobic capacity. During RAAM training distress score (TDS) and body mass were measured daily. Power output and heart rate (HR) were measured during cycling. Blood sampling for proteomic analysis occurred 4 weeks, 24, and 2 h before the start, twice per day of the race, and after 1 and 4 days recovery.

resultsThe athlete completed the 4941 km race in 10.1 days at a speed of 24.5 km/h with 20 total hours of sleep. TDS was very low, 1, pre-RAAM and increased to very high, 47, at the finish. Post-RAAM maximal aerobic capacity and HR were 6.3 and 5.7% lower (61.6 vs. 57.5 mL.kg

conclusionThe RAAM athlete exhibited non-functional overreaching symptoms including increased training distress and decreased work capacity. Proteomic analysis indicated large increases for immune-related proteins involved with complement activation and the acute phase response, which could be useful biomarkers for non-functional overreaching.

Indexed as

cyclingoverreachovertraining syndromeproteomicsRAAMultraendurance

Identifiers

PMID31798466
PMCPMC6874140
OpenAlexW2985427591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.